Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
July 5, 2003
Statins sentence thyroid cancer cells to death rho
Richard J Robbins
Methodist Debakey Cardiovascular Journal
|
July 26, 2017
Hormones and the Heart
Richard J Robbins, Steven Petak
Best Practice & Research. Clinical Endocrinology & Metabolism
|
December 2, 2008
The value of positron emission tomography (PET) in the management of patients with thyroid cancer
Richard J Robbins, Steven M Larson
Methodist Debakey Cardiovascular Journal
|
July 28, 2010
The cardiovascular effects of hyperthyroidism
Lara A Nabbout, Richard J Robbins
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 18, 2005
The evolving role of (131)I for the treatment of differentiated thyroid carcinoma
Richard J Robbins, Martin J Schlumberger
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 5, 2003
Coming of age: recombinant human thyroid-stimulating hormone as a preparation for (131)i therapy in thyroid cancer
Richard J Robbins, Keith S Pentlow
Case Reports in Endocrinology
|
May 9, 2022
Myxedema Coma Associated with Macroprolactinoma: Case Report and Review of the Literature
Elizabeth Jasola Omoniyi, Richard J Robbins
The Journal of Clinical Endocrinology and Metabolism
|
May 3, 2003
Clinical review 156: Recombinant human thyrotropin and thyroid cancer management
Richard J Robbins, Anne K Robbins
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2005
Distilling cancer biomarkers from the serum peptidome: high technology reading of tea leaves or an insight to clinical systems biology?
Richard J Robbins, Josep Villanueva, Paul Tempst
Thyroid : Official Journal of the American Thyroid Association
|
November 25, 2006
Recombinant human thyrotropin-assisted radioiodine therapy for patients with metastatic thyroid cancer who could not elevate endogenous thyrotropin or be withdrawn from thyroxine
Richard J Robbins, Albert Driedger, James Magner, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
The Journal of Clinical Endocrinology and Metabolism
|
July 5, 2003
Statins sentence thyroid cancer cells to death rho
Richard J Robbins
Methodist Debakey Cardiovascular Journal
|
July 26, 2017
Hormones and the Heart
Richard J Robbins, Steven Petak
Best Practice & Research. Clinical Endocrinology & Metabolism
|
December 2, 2008
The value of positron emission tomography (PET) in the management of patients with thyroid cancer
Richard J Robbins, Steven M Larson
Methodist Debakey Cardiovascular Journal
|
July 28, 2010
The cardiovascular effects of hyperthyroidism
Lara A Nabbout, Richard J Robbins
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 18, 2005
The evolving role of (131)I for the treatment of differentiated thyroid carcinoma
Richard J Robbins, Martin J Schlumberger
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 5, 2003
Coming of age: recombinant human thyroid-stimulating hormone as a preparation for (131)i therapy in thyroid cancer
Richard J Robbins, Keith S Pentlow
Case Reports in Endocrinology
|
May 9, 2022
Myxedema Coma Associated with Macroprolactinoma: Case Report and Review of the Literature
Elizabeth Jasola Omoniyi, Richard J Robbins
The Journal of Clinical Endocrinology and Metabolism
|
May 3, 2003
Clinical review 156: Recombinant human thyrotropin and thyroid cancer management
Richard J Robbins, Anne K Robbins
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2005
Distilling cancer biomarkers from the serum peptidome: high technology reading of tea leaves or an insight to clinical systems biology?
Richard J Robbins, Josep Villanueva, Paul Tempst
Thyroid : Official Journal of the American Thyroid Association
|
November 25, 2006
Recombinant human thyrotropin-assisted radioiodine therapy for patients with metastatic thyroid cancer who could not elevate endogenous thyrotropin or be withdrawn from thyroxine
Richard J Robbins, Albert Driedger, James Magner, et al.
Page
of 4